In Silico Methods for Predicting Drug Toxicity

QSAR Methods.- InSilico 3D-Modelling of Binding Activities.- Modeling Pharmacokinetics.- ModelingADMET.- In Silico Prediction of Chemically-Induced Mutagenicity: How to UseQSAR Models and Interpret Their Results.- In Silico Methods for CarcinogenicityAssessment.- VirtualToxLab: Exploring the Toxic Potential of RejuvenatingSubstances Found in Traditional Medicines.- In Silico Model for DevelopmentalToxicity: How to Use QSAR Models and Interpret Their Results.- In Silico Modelsfor Repeated Dose Toxicity (RDT): Prediction of the No Observed Adverse EffectLevel (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.- InSilico Models for Acute Systemic Toxicity.- In Silico Models forHepatotoxicity.-In Silico Models for Ecotoxicity of Pharmaceuticals.- Use of Read-Across Tools.-Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity.- A SystemsBiology Approach for Identifying Hepatotoxicant Groups Based on Similarity inMechanisms of Action and Chemical Structure.- In Silico Study of In Vitro GPCRAssays by QSAR Modeling.- Taking Advantage of Databases.- QSAR Models at theUnited States FDA/NCTR.- A Round Trip from Medicinal Chemistry to PredictiveToxicology.- The Use of In Silico Models Within a Large Pharmaceutical Company.-The Consultancy Activity on In Silico Models for Genotoxic Prediction ofPharmaceutical Impurities.